Company
ABOUT CELLMOTIVE
At Cellmotive, we believe that growth is
achieved when individuals work together,
empowered by autonomy and collaboration.
We are dedicated to the continuous exploration, research, and innovation needed to adapt to a constantly evolving world — embodying the resilience and vitality of true pioneers.
Our ultimate aspiration is to become an organization that positively impacts people’s lives, much like an entity with a living spirit.
CEO Ji-Young Ha
Education
- Ph.D. in Pharmacy, Ewha Womans University
- Bachelor of Pharmacy, Ewha Womans University (Licensed Pharmacist)
Career
-
Ministry of Food and Drug Safety (MFDS), Korea
- Conducted scientific assessments and regulatory reviews related to pharmaceutical products and safety standards.
- Performed quality evaluations and inspection tasks for pharmaceuticals and cosmetics.
Lecturer
-
Department of Pharmaceutical New Materials, Hallym University | Korea
- Delivered lectures and supervised research on toxicology, drug approval and regulatory affairs, pharmacology, drug delivery systems, and pharmaceutical Good Manufacturing Practices (GMP).
- Specialized in pharmaceutical material innovation and the development of regulatory science expertise.
Key Milestones
- Jul 2022 Established Cellmotive Co., Ltd. and formed its Board of Directors
- Oct 2023 Achieved certification as a Women-Owned Business
- Nov 2023 Launched technology transfer exploration and partnership initiatives
- Feb 2024 Granted Patent No. 10-2635166
- May 2024 Finalized the technology transfer for Patent No. 10-2405455
- Dec 2024 Officially registered as a Certified Research Institute Company
Partner Institution
- Gangwon National University
